In contrast, tumours expressing only high HER1 or HER2 but low HER3 or HER4 correlated with poor prognostic parameters of bladder cancer (late stage of tumour (T2–T4), high-grade (Grade III/IV) and solid type of tumour). This evidence concerns the gene ERBB2 and urinary bladder carcinoma.